Rochester receives $1M FDA, BDRSA grant to begin first controlled clinical trial in Juvenile Batten disease
Links shared publicly online about this topic.
- 251total visits
Rochester receives $1M FDA, BDRSA grant to begin first controlled clinical trial in Juvenile Batten disease
After years of building hope for a treatment, Rochester researchers and clinicians will begin the first controlled clinical trial for Juvenile Batten disease this summer, thanks to $1 million in grants from the Food and Drug Administration and the Batten Disease Support and Research Association.
View full resource at news-medical.net
Tags: Disease and Condition, Diet and Nutrition, Drug, Clinical Trial, Children's Health, FDA, disease
Most Recently Shared on June 1, 2011 at 5:45 am By:
Rochester receives $1M FDA, BDRSA grant to begin first controlled clinical trial in Juvenile Batten disease: Aft... http://bit.ly/kVYHz0
Advertisement
